Overview
Orderly Wellness provides telehealth weight-management by connecting patients with licensed clinicians across all 50 states who can prescribe GLP-1 medications like Semaglutide and Tirzepatide. Its direct-to-consumer, cash-pay model handles consultation, prescription, and medication delivery entirely online, with month-to-month or multi-month pricing. Beyond meds, it offers 360-degree care—mental health support, nutrition guidance, fitness coaching, and a digital community—using health data such as bloodwork and DNA to personalize plans. It operates as a marketplace partnering with independent providers and pharmacies, and in 2025 began manufacturing by leasing a large Florida facility to produce medications and create jobs.
Work here?Claim your company
Simplify's Take
What believers are saying
- OrderlyMeds says 125,000 customers have used it and lost over 1 million pounds.
- Its Tampa manufacturing lease and hiring plan signal vertical integration and margin expansion.
- LinkedIn listed 51-200 employees on September 1, 2026, showing continued operating scale.
What critics are saying
- FDA's June 8, 2026 warning letter targets misleading compounded semaglutide and tirzepatide claims.
- If compounded GLP-1 sourcing tightens, OrderlyMeds' core offering collapses quickly.
- The business depends on regulatory tolerance for telehealth compounding, now under direct scrutiny.
What makes Orderly Wellness unique
- OrderlyMeds bundles GLP-1s with therapy, nutrition, fitness, and community support.
- Its 50-state clinician network and cash-pay checkout remove insurance friction.
- The September 9, 2026 Veo Health partnership adds biomarker testing and coaching.
Help us improve and share your feedback! Did you find this helpful?